Routine plain film of abdomen in asymptomatic patients with video capsule retention in small bowel-time to change practice?

Abstract

Aim: Small bowel capsule retention is rare, with a rate of approximately 2%, defined as visible retention on plain film of abdomen (PFA) after 14 days. Currently, PFA is performed if the capsule is not seen to reach the large bowel during recording. Alternatively, for upper gastrointestinal (UGI) capsule studies, the risk of retention is determined if the capsule fails to reach the small bowel during recording. Given the similar physical specifications of the capsules (Medtronic) used, we considered whether 14-day PFA is no longer required for small bowel capsules not observed in the large bowel.

Methods: The use of patency capsules in our lab allows careful selection of small bowel capsule studies to minimize the risk of retention. All PFAs performed over a five-year period were reviewed to determine if careful selection and use of patency negate the need for capsule retention PFA screening.

Results: In total, 688 small-bowel capsules were performed during the study period, and 3.6% had prior patency capsules. Thirty-one PFAs with a query of capsule retention were performed during the study period on 28 patients. This included 15 females, and the median age was 53.5 years. None of the films demonstrated capsule retention.

Conclusion: Our data suggest that 14-day PFA may no longer be required for small bowel capsules not seen to reach the large bowel. Advice regarding symptoms of capsule retention and precaution with magnetic resonance imaging, similar to current UGI capsule advice, may suffice. This may reduce the burden on radiology imaging slots and, in particular, eliminate unnecessary radiation exposure and repeat hospital attendance for patients.

Keywords

Video capsule endoscopy / plain film abdomen / asymptomatic

References

[1] Iddan G,Glukhovsky A.Wireless capsule endoscopy.Nature2000;405:417

[2] Rondonotti E,Adler S.Small-bowel capsule endoscopy and device-assisted enteroscopy for diagnosis and treatment of small-bowel disorders: European society of gastrointestinal endoscopy (ESGE) technical review.Endoscopy2018;50:423-46

[3] Zammit S, Sidhu R. Capsule endoscopy-recent developments and future directions.Expert Rev Gastroenterol Hepatol2021;15:127-37

[4] Rondonotti E.Capsule retention: prevention, diagnosis and management.Ann Transl Med2017;5:198 PMCID:PMC5438794

[5] Sachdev MS,Fleischer DE.A prospective study of the utility of abdominal radiographs after capsule endoscopy for the diagnosis of capsule retention.Gastrointest Endosc2007;66:894-900

[6] Al-Bawardy B,Huprich JE.Retained capsule endoscopy in a large tertiary care academic practice and radiologic predictors of retention.Inflamm Bowel Dis2015;21:2158-64

[7] Fernández-Urién I,González B.Incidence, clinical outcomes, and therapeutic approaches of capsule endoscopy-related adverse events in a large study population.Rev Esp Enferm Dig2015;107:745-52

[8] Pennazio M,Eliakim R.Small-bowel capsule endoscopy and device-assisted enteroscopy for diagnosis and treatment of small-bowel disorders: European society of gastrointestinal endoscopy (ESGE) clinical guideline.Endoscopy2015;47:352-76

[9] Viazis N,Saprikis E. A single center experience of 2300 consecutive patients undergoing capsule endoscopy: indications and diagnostic yield. Endoscopy 2011;43:A129.

[10] Nemeth A,Nielsen J,Toth E.Capsule retention related to small bowel capsule endoscopy: a large European single-center 10-year clinical experience.United European Gastroenterol J2017;5:677-86 PMCID:PMC5548346

[11] Enns RA,Armstrong D.Clinical practice guidelines for the use of video capsule endoscopy.Gastroenterology2017;152:497-514